Beijing QL Biopharmaceutical Co.,Ltd

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Phase 32

Phase 21

Phase 11

By Therapeutic Area

top 1

Metabolic & Endocrine

4100%

R&D Momentum

51/100

Pipeline Velocity

27/100

Trial Completion Rate

100/100

Pipeline Concentration

100/100

Pipeline Freshness

95/100

Activity

Recent Activity

Last 14 days

Oct 22, 2026

Active, not recruiting

A Phase I Clinical Study to Evaluate the Pharmacokinetic Characteristics and Safety of Single-dose of Zovaglutide (ZT002 Injection) in Participants With Different Degrees of Renal Insufficiency and Matched Participants With Normal Renal Function

Oct 22, 2026

Active, not recruiting

A Drug-drug Interaction Study to Evaluate the Impact of Multiple Subcutaneous Injections of ZT002 on the Pharmacokinetics of Metformin, Warfarin, Rosuvastatin and Digoxin in Overweight and Obese Participants

Earlier

Oct 22, 2026TrialPhase 1, Single-Center, Randomized, Double-Blind, Parallel-Group Placebo-Controlled（Concentration）-QTc（C-QTc）Study to Evaluate the Impact of ZT002 Injection on QTc Interval in Chinese Overweight and Obese Subjects

Sep 11, 2026TrialA Multicenter, Randomized, Active-Controlled, Open-Label Phase IIb Study Evaluating Safety and Tolerability of Switching to Zovaglutide Injection After Titration to 2.4 mg Semaglutide Injection (Wegovy®) in Adults With Obesity (HORIZON-SWITCH-SZ)

Aug 4, 2026TrialA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Zovaglutide in Adults With Overweight or Obesity.

Jul 28, 2026TrialA Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZT003 Injection in Healthy Volunteers and Overweight or Obese Volunteers

Dec 12, 2025TrialEfficacy and Safety of ZT006 in Overweight and Obese Participants

Nov 28, 2024TrialDose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese Participants

3 more events

Aug 14, 2024TrialA Study of ZT002 Injection With Subjects With Overweight or Obesity

Feb 19, 2024TrialA Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)

Nov 21, 2023TrialA Study of ZT002 Injection in Participants With Overweight or Obesity

Details